Strategies for AIDS vaccines

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. B, 1996, Pages 185-198

  Stott, E J ^a   Schild, G C ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VIRUS VACCINE; LIVE VACCINE; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; MACACA; NONHUMAN; PROVOCATION TEST; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN CELL; VIRION;

EID: 0029788458     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_b.185     Document Type: Conference Paper

References (68)

1. Ahmed, S., Lohman, B., Marthas, M., Giavedoni, L., El-Amad, Z., Haigwood, N. et al. (1994). Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses 10, 195-204.
2. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B. & Stott, E. J. (1995). Attenuated simian immunodeficiency virus protects macaques against challenge with virus infected cells. Lancet 345, 1342-4.
3. Arthur, L. O., Bess, J. W., Waters, D. J., Pyle, S. W., Kelliher, J. C., Nara, P. L. et al. (1989). Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp 120. Journal of Virology 63, 5046-53.
4. Arthur, L. O., Bess, J. W., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J.-C. et al. (1992). Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258, 1935-8.
5. Arthur, L. O., Bess, J. W., Urban, R. G., Strominger, J. L., Morton, W. R., Mann, D. L. et al. (1995). Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. Journal of Virology 69, 3117-24.
6. Azocar, J. & Essex, M. (1979). Incorporation of HLA antigens into the envelope of RNA tumour viruses grown in human cells. Cancer Research 39, 3388-91.
7. Baba, T. W., Jeong, Y. S., Pennich, D., Bronson, R., Greene, M. F. & Ruprecht, R. M. (1995). Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-5.
8. Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P. et al. (1990). Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622-5.
9. Bonhoeffer, S. & Nowak, M. (1995). Can live attenuated virus work as post-exposure treatment? Immunology Today 16, 131-4.
10. Bruck, C., Thiriart, C., Fabry, L., Francotte, M., Pala, P., Van Opstal, O. et al. (1994). HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12, 1141-8.
11. Bubbers, J. R. & Lilly, F. (1977). Selective incorporation of H-2 antigenic determinants into Freund virus particles. Nature 266, 458-9.
12. Carlson, J. R., McGraw, T. P., Keddie, E., Yee, J. L., Rosenthall, A., Langlois, A. J. et al. (1990). Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Research & Human Retroviruses 6, 1239-46.
13. Chan, W. L., Rodgers, A., Hancock, R., Taffs, F., Kitchin, P., Farrar, G. et al. (1992). Protection in SIV-vaccinated monkeys correlates with anti-HLA class I antibody response. Journal of Experimental Medicine 176, 1203-7.
14. Chan, W. L., Rodgers, A., Grief, C., Almond, A., Ellis, S., Flanagan, B. et al. (1995). Immunization with Class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac 32H. AIDS 9, 223-8.
15. Chao, A., Bulterrys, M., Musanganire, F., Habimana, P., Nowrocki, P., Taylor, E. et al. (1994). Risk factors associated with prevalent HIV-1 infection among pregnant women in Rwanda. International Journal of Epidemiology 23, 317-80.
16. Cranage, M. P., Ashworth, L. A. E., Greenaway, P. J., Murphey-Corb, M. & Desrosiers, R. (1992a). AIDS vaccine development. Nature 355, 685-6.
17. Cranage, M. P., Baskerville, A., Ashworth, L. A. E., Dennis, M., Cook, N., Sharpe, S., Farrar, G. et al. (1992b). Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339, 273-4.
18. Cranage, M. P., Polyanskaya, N., McBride, B., Cook, N., Ashworth, L. A. E., Dennis, M. et al. (1993). Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Research & Human Retroviruses 9, 13-22.
19. Daniel, M. D., Kirchoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective efforts of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-41.
20. Desrosiers, R. C., Wyand, M. S., Kodama, T., Ringler, D. J., Arthur, L. O., Sehgal, P. K. et al. (1989). Vaccine protection against simian immunodeficiency virus infection. Proceedings of the National Academy of Science, USA 86, 6353-7.
21. Emini, E. A., Schleif, W. A., Nunberg, J. H., Conley, A. J., Eda, Y., Tokiyoshi, S. et al. (1992). Prevention of HIV-1 infection in chimpanzees by gp1230 V3 domain specific monoclonal antibody. Nature 355, 728-30.
22. European Community Concerted Action on Macaque Models for AIDS Research. (1995). Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine 13, 295-300.
23. Fultz, P. N., Nara, P., Barre-Sinoussi, F., Chaput, A., Greenberg, M. L., Muchmore, E. et al. (1992). Vaccine protection of chimpanzees against challenge with HIV-1 infected peripheral blood mononuclear cells. Science 256, 1687-90.
24. Gardner, M. B., Jennings, M., Carlson, J. R., Lerche, N., McGraw, T., Luciw, P. et al. (1989). Postexposure immunotherapy of simian immunodeficiency virus (SIV) infected rhesus with an SIV immunogen. Journal of Medical Primatology 18, 321-8.
25. Gardner, M. B. & Murphy-Corb, M. (1990). Vaccine protection of rhesus monkeys against homologous and heterologous strains of SIV. In Hutiéme Colloque de Cent Garde (Girard, M. & Valette, L., Eds), pp. 221-6. Foundation, Lyon.
26. Gelderblom, H., Reupke, H., Winkel, T., Kunze, R. & Pauli, G. (1987). MHC antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z Naturforsch C 42, 1328-34.
27. Giavedoni, L. P., Planelles, V., Haigwood, N. L., Ahmed, S., Kluge, J. D., Marthas, M. L. et al. (1993). Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. Journal of Virology 67, 577-83.
28. Girard, M., Kieny, M.-P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H. et al. (1991). Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proceedings of the National Academy of Science, USA 88, 542-6.
29. Henderson, L. E., Sowder, R., Copeland, T. D., Oroszlan, S., Arthur, L. O., Robey, W. G. et al. (1987). Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. Journal of Virology 61, 629-32.
30. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-6.
31. Hoxie, J. A., Fitzharris, T. P., Youngbar, P. R., Matthews, D. M., Rackowski, J. L. & Radka, S. F. (1987). Non-random association of cellular antigens with HTLV-III virions. Human Immunology 18, 39-52.
32. Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J. et al. (1992). Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255, 456-9.
33. Israel, Z. R., Edmonson, P. F., Maul, D. H., O'Neil, S. P., Mossman, S. P., Thiriart, C. et al. (1994). Incomplete protection but suppression of virus burden elicited by subunit simian immunodeficiency virus vaccines. Journal of Virology 68, 1843-53.
34. Johnson, P. R., Montefiori, D. C., Goldstein, S., Hamm, T. E., Zhou, J., Kitov, S. et al. (1992a). Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proceedings of the National Academy of Science, USA 89, 2175-9.
35. Johnson, P. R., Montefiori, D. E., Goldstein, S., Hamm, T. E., Zhon, J., Kitov, S. et al. (1992b). Inactivated whole SIV vaccine in macaques: Evaluation of protective efficacy against challenge with cell-free virus infected cells. AIDS Research Human Retroviruses 8, 1501-5.
36. Kent, K., Rud, E., Corcoran, T., Powell, C., Thiriart, C., Collignon, C. et al. (1992). Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Research & Human Retroviruses 8, 737-41.
37. Kent, K. A., Kitchin, P., Mills, K. H. G., Page, M., Taffs, L. F., Corcoran, T. et al. (1994). Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Research & Human Retroviruses 10, 189-94.
38. Kestler, H. W., Li, Y., Naidu, M., Butler, C. V., Ochs, M. F., Jaenel, G. et al. (1988). Comparison of simian immunodeficiency virus isolates. Nature (London) 331, 619-20.
39. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-62.
40. Le Grand, R., Vogt, G., Vaslin, B., Roques, P., Theodoro, F., Aubertin, A.-M. et al. (1992). Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 10, 873-9.
41. Lewis, M. G., Elkins, W. R., McCutchan, E. F., Benveniste, R. E., Lai, C. Y., Montefiori, D. C. et al. (1993). Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine 11, 1347-55.
42. Li, J., Lord, C. I., Haseltine, W., Letvin, N. L. & Sodroski, J. (1992). Infection of cynomolgus macaques with a chimearic HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. Journal of AIDS 5, 639-46.
43. Mannhalter, J. W., Pum, M., Wolf, H. M., Kupcu, Z., Barrett, F., Dorner F. et al. (1991). Immunization of chimpanzees with the HIV-1 glycoprotein gp160 induces long-lasting T-cell memory. AIDS Research & Human Retroviruses 7, 485-93.
44. Marthas, M. L., Sutjipto, S., Higgins, J., Lohman, B., Torten, J., Luciou, P. A. et al. (1990). Immunization with a live attenuated simian immunodeficiency virus (SIV) presents early disease, but not infection in rhesus macaques challenged with pathogenic SIV. Journal of Virology 64, 3694-700.
45. Mertens, T. E., Burton, A., Stoneburner, R., Sato, P., Beer, D. L., Carael, M. et al. (1994). Global estimates and epidemiology of HIV infections and AIDS. AIDS 8, Suppl. 1, S361-72.
46. Mills, K. H. G., Barnard, A. L., Williams, M., Page, M., Ling, C., Stott, E. J. et al. (1991). Vaccine induced CD4+ T-cells against the simian immunodeficiency virus gag protein. Journal of Immunology 147, 3560-7.
47. Mills, K. H. G., Page, M., Chan, W. L., Kitchin, P., Stott, E. J., Taffs, L. F. et al. (1992). Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone but not with BK28-derived recombinant env and gag proteins. Journal of Medical Primatology 21, 50-8.
48. Mills, K. H. G., Page, M., Kitchin, P., Chan, W. L., Jones, W., Silvera, P. et al. (1993). Immunization of macaques with SIV env recombinants: specificity of T-cell and antibody responses and evaluation of protective efficacy. Journal of Medical Primatology 21, 104-9.
49. Mitchell, T. & Risser, R. (1992). Interference established in mice by infection with Freund murine leukaemia virus. Journal of Virology 66, 5696-702.
50. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, C., Miller, M., West, M. et al. (1989). A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-7.
51. Ohkawa, S., Wilson, L. A., La Rosa, G., Javaherian, K., Martin, L. N. & Murphey-Corb, M. (1994). Immune responses induced by prototype vaccines for AIDS in rhesus monkeys. AIDS Research and Human Retroviruses 10, 27-38.
52. Osterhaus, A., de Vries, P., Morein, B., Akerblom, L. & Heeney, J. (1992). Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanated Formalin-inactivated SIV vaccines from i.v. cell-free or cell-associated homologous challenge. AIDS Research and Human Retroviruses 8, 1507-10.
53. Putkonen, P., Thorstensson, R., Albert, J., Hild, K., Norrby, E., Biberfeld, P. et al. (1990). Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4, 783-9.
54. Putkonen, P., Thorstensson, R., Walther, L., Albert, J., Akerblom, L., Granquist, O. et al. (1991). Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Research and Human Retroviruses 7, 271-7.
55. Putkonen, P., Thorstensson, R., Cranage, M., Nilsson, C., Ghavamzadeh, L., Albert, J. et al. (1992). A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge. Journal of Medical Primatology 21, 108-12.
56. Rud, E. W., Cranage, M., Yon, J., Quirk, J., Ogilvie, L., Cook, N. et al. (1994). Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. Journal of General Virology 75, 529-43.
57. Sabin, A. B. (1992). Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proceedings of the National Academy of Science, USA 89, 8852-5.
58. Shafferman, A., Lewis, M. G., McCutchan, F. E., Benveniste, R. E., Jahrling, P. B., Burke, D. S. et al. (1993). Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. Vaccine 11, 849-52.
59. Silvera, P., Flanagan, B., Kent, K., Rud, E., Powell, C., Corcoran, T. et al. (1994). Fine analysis of the humoral antibody response to the envelope glycoprotein of SIV in infected and vaccinated macaques. AIDS Research and Human Retroviruses 10, 1295-304.
60. Stott, E. J., Chan, W. L., Mills, K. H. G., Page, M., Taffs, F., Cranage, M. et al. (1990). Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by a whole fixed cell vaccine. Lancet 336, 1538-41.
61. Stott, E. J., Kitchin, P. A., Page, M., Flanagan, B., Taffs, L. F., Chan, W. L. et al. (1991). Anti-cell antibody in macaques. Nature 353, 393.
62. Stott, E. J., Cranage, M. P., Kitchin, P. A., Kent, K., Farrar, G., Taffs, L. F. et al. (1992). Vaccination against simian immunodeficiency virus infection of macaques. In Sixiéme Colloque des Cent Gardes (Girard, M. & Valette, L., Eds), pp. 261-6. Foundation Merieux, Lyon.
63. Stott, E. J., Almond, N., Kent, K. A., Chan, W. L., Cranage, M. P., Kitchin, P. A. et al. (1994) Animal models in the development of AIDS vaccines. In Huitiéme Colloque Des Cent Gardes (Girard, M. & Valette, L., Eds), pp. 131-7. Foundation Merieux, Lyon.
64. Sutjipto, S., Pedersen, N. C., Miller, C. J., Gardner, M. B., Hanson, C. V., Gettie, A. et al. (1990). Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. Journal of Virology 64, 2290-7.
65. Walker, M. C. & Fast, P. E. (1994). Clinical trials of candidate AIDS vaccines. AIDS 8, Suppl., S213-36.
66. Warren, J. T. & Dolatshahi, M. (1993). First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in non-human primates: progress in first and second order studies. Journal of Medical Primatology 22, 203-35.
67. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P. et al. (1995). Viral dynamics in human immunodeficiency virus type I infection. Nature 373, 117-22.
68. Yasutomi, Y., Koenig, S., Woods, R. M., Madsen, J., Wassef, N. M., Alving, C. R. et al. (1995). A vaccine elicited single viral epitope specific cytotoxic T lymphocyte response does not protect against intravenous cell free simian immunodeficiency virus challenge. Journal of Virology 69, 2279-84.